$MBRX METABASIS THERAPEUTICS INC Insider Trading
Get free email notifications about insider trading in METABASIS THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in METABASIS THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in METABASIS THERAPEUTICS INC for free.
IRS Number: 330753322
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: MBRX
Company Address: 9390 TOWNE CENTRE DRIVE SAN DIEGO 92121
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.
Market Capitalization: $18.08M
Prev close: $1.80
Average Daily Volume: 157,258
Days Low: $1.50
Year Low: $1.41
Year High: $9.58
METABASIS THERAPEUTICS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2010 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Sell | D | 0.00 | 4,814,725 | 0 | 0 | 4.8 M to 0 (-100.00 %) |
| Jan 29 2010 | MBRX | METABASIS THERAPEU ... | MPM BIOVENTURES II QP LP | 10% Owner | Sell | D | 0.00 | 4,814,725 | 0 | 0 | 4.8 M to 0 (-100.00 %) |
| Jun 25 2009 | MBRX | METABASIS THERAPEU ... | Stoner Elizabeth | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
| Jun 25 2009 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
| Jun 25 2009 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Director | Option Exercise | A | 0.41 | 5,000 | 2,050 | 5,000 | |
| Jun 25 2009 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
| Jun 24 2009 | MBRX | METABASIS THERAPEU ... | Schreiner George | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
| Jun 24 2009 | MBRX | METABASIS THERAPEU ... | ROHN WILLIAM R | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
| Jun 24 2009 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
| Jun 24 2009 | MBRX | METABASIS THERAPEU ... | BURGESS DANIEL D | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
| Mar 02 2009 | MBRX | METABASIS THERAPEU ... | Nguyen Tran | VP and CFO | Option Exercise | A | 0.35 | 250,000 | 87,500 | 250,000 | |
| Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Executive Off ... | Option Exercise | D | 1.00 | 240,000 | 240,000 | 240,000 | |
| Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Executive Off ... | Option Exercise | D | 2.10 | 90,000 | 189,000 | 0 | |
| Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Executive Off ... | Option Exercise | D | 7.55 | 75,000 | 566,250 | 0 | |
| Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Executive Off ... | Option Exercise | D | 9.03 | 75,000 | 677,250 | 0 |